A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease (Q33292093)

25 July 2017

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease (English)

1 reference

25 July 2017

0 references

0 references

4

1 reference

25 July 2017

Janus C

1

1 reference

25 July 2017

Pearson J

2

1 reference

25 July 2017

McLaurin J

3

1 reference

25 July 2017

Jiang Y

5

1 reference

25 July 2017

Schmidt SD

6

1 reference

25 July 2017

Chishti MA

7

1 reference

25 July 2017

Horne P

8

1 reference

25 July 2017

Heslin D

9

1 reference

25 July 2017

French J

10

1 reference

25 July 2017

Mount HT

11

1 reference

25 July 2017

Nixon RA

12

1 reference

25 July 2017

Mercken M

13

1 reference

25 July 2017

Bergeron C

14

1 reference

25 July 2017

Fraser PE

15

1 reference

25 July 2017

St George-Hyslop P

16

1 reference

25 July 2017

Westaway D

17

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

25 July 2017

1 reference

25 July 2017

408

1 reference

25 July 2017

6815

1 reference

25 July 2017

979-982

1 reference

https://scigraph.springernature.com/pub.10.1038/35050110

25 July 2017

0 references

cites work

Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease

1 reference

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

7 January 2021

Clinical trial designs for demonstrating disease-course-altering effects in dementia.

1 reference

7 January 2021

Developments of a water-maze procedure for studying spatial learning in the rat

1 reference

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

7 January 2021

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

7 January 2021

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

1 reference

7 January 2021

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

1 reference

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

7 January 2021

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

1 reference

7 January 2021

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

1 reference

7 January 2021

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

7 January 2021

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

7 January 2021

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

1 reference

7 January 2021

Antibody clears senile plaques

1 reference

7 January 2021

A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor

1 reference

7 January 2021

Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest

1 reference

7 January 2021

Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes.

1 reference

7 January 2021

Hippocampal protein kinase C activity is reduced in poor spatial learners.

1 reference

7 January 2021

Comparison of four staining methods on the detection of neuritic plaques

1 reference

7 January 2021

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

7 January 2021

Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice

1 reference

7 January 2021

Variable-interval probe test as a tool for repeated measurements of spatial memory in the water maze.

1 reference

7 January 2021

Identifiers

DOI

10.1038/35050110

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference